Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.

Qu J, Zhao L, Zhang P, Wang J, Xu N, Mi W, Jiang X, Zhang C, Qu J.

J Cell Physiol. 2015 Mar;230(3):535-45. doi: 10.1002/jcp.24366.

PMID:
23526568
2.

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.

Hu Y, Xu K, Yag├╝e E.

Breast Cancer Res Treat. 2015 Jun;151(2):269-80. doi: 10.1007/s10549-015-3372-9. Epub 2015 Apr 22.

PMID:
25900794
3.

MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.

Chai J, Dong W, Xie C, Wang L, Han DL, Wang S, Guo HL, Zhang ZL.

IUBMB Life. 2015 Mar;67(3):191-201. doi: 10.1002/iub.1361. Epub 2015 Apr 15.

4.

MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5.

Yang G, Jiang O, Ling D, Jiang X, Yuan P, Zeng G, Zhu J, Tian J, Weng Y, Wu D.

Mol Med Rep. 2015 Sep;12(3):3930-6. doi: 10.3892/mmr.2015.3890. Epub 2015 Jun 4.

PMID:
26043974
5.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
6.

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, Xiong W, Li G, Lu J, Fodstad O, Riker AI, Tan M.

J Biol Chem. 2010 Jul 9;285(28):21496-507. doi: 10.1074/jbc.M109.083337. Epub 2010 May 11.

7.

miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.

Chatterjee A, Chattopadhyay D, Chakrabarti G.

PLoS One. 2014 Apr 22;9(4):e95716. doi: 10.1371/journal.pone.0095716. eCollection 2014.

8.

Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.

Kurokawa K, Tanahashi T, Iima T, Yamamoto Y, Akaike Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima M, Rokutan K.

J Gastroenterol. 2012 Aug;47(8):883-95. doi: 10.1007/s00535-012-0547-6. Epub 2012 Mar 1.

PMID:
22382630
9.

MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.

He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan FK, Sung JJ, Yu J.

Mol Med. 2013 Feb 8;18:1491-8. doi: 10.2119/molmed.2012.00304.

10.

MiR-5000-3p, miR-5009-3P and miR-552: potential microRNA biomarkers of side population cells in colon cancer.

Xia ZS, Wang L, Yu T, Zhong W, Lian GD, Wu D, Zhou HM, Chen GC.

Oncol Rep. 2014 Aug;32(2):589-96. doi: 10.3892/or.2014.3232. Epub 2014 Jun 4.

PMID:
24898979
11.

miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.

Su SF, Chang YW, Andreu-Vieyra C, Fang JY, Yang Z, Han B, Lee AS, Liang G.

Oncogene. 2013 Sep 26;32(39):4694-701. doi: 10.1038/onc.2012.483. Epub 2012 Oct 22.

12.

MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.

Shang J, Yang F, Wang Y, Wang Y, Xue G, Mei Q, Wang F, Sun S.

J Cell Biochem. 2014 Apr;115(4):772-84. doi: 10.1002/jcb.24721.

PMID:
24249161
13.

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP.

Mol Cancer Ther. 2008 Jul;7(7):2152-9. doi: 10.1158/1535-7163.MCT-08-0021.

14.

Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.

Saxena A, Shoeb M, Ramana KV, Srivastava SK.

Eur J Cancer. 2013 Oct;49(15):3311-9. doi: 10.1016/j.ejca.2013.05.031. Epub 2013 Jul 1.

15.

Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.

Li X, Zhao H, Zhou X, Song L.

Mol Med Rep. 2015 Jan;11(1):577-82. doi: 10.3892/mmr.2014.2726. Epub 2014 Oct 21.

PMID:
25333573
16.

Induction of the cellular microRNA-29c by influenza virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors BCL2L2.

Guan Z, Shi N, Song Y, Zhang X, Zhang M, Duan M.

Biochem Biophys Res Commun. 2012 Aug 31;425(3):662-7. doi: 10.1016/j.bbrc.2012.07.114. Epub 2012 Jul 28.

PMID:
22850539
17.

Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.

Deng J, Lei W, Fu JC, Zhang L, Li JH, Xiong JP.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):789-95. doi: 10.1016/j.bbrc.2013.11.064. Epub 2013 Nov 23.

PMID:
24275137
18.

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.

Zhang X, Huang L, Zhao Y, Tan W.

Acta Biochim Biophys Sin (Shanghai). 2013 Dec;45(12):995-1001. doi: 10.1093/abbs/gmt113. Epub 2013 Oct 20.

PMID:
24145606
19.

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.

Li J, Chen Y, Zhao J, Kong F, Zhang Y.

Cancer Lett. 2011 May 1;304(1):52-9. doi: 10.1016/j.canlet.2011.02.003. Epub 2011 Feb 26.

PMID:
21354697
20.

Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Wang BD, Kline CL, Pastor DM, Olson TL, Frank B, Luu T, Sharma AK, Robertson G, Weirauch MT, Patierno SR, Stuart JM, Irby RB, Lee NH.

Mol Cancer. 2010 Apr 30;9:98. doi: 10.1186/1476-4598-9-98.

Items per page

Supplemental Content

Write to the Help Desk